Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Net Cash Flow (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Net Cash Flow readings, the most recent being -$23.6 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 1519.15% to -$23.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$18.7 million, a 81.05% increase, with the full-year FY2025 number at -$18.7 million, up 81.05% from a year prior.
  • Net Cash Flow hit -$23.6 million in Q4 2025 for Aligos Therapeutics, down from $23.3 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $65.3 million in Q4 2023 to a low of -$111.4 million in Q1 2024.
  • Median Net Cash Flow over the past 5 years was -$7.4 million (2022), compared with a mean of -$10.1 million.
  • Biggest five-year swings in Net Cash Flow: soared 1390.45% in 2023 and later plummeted 4551.65% in 2024.
  • Aligos Therapeutics' Net Cash Flow stood at -$53.4 million in 2021, then soared by 90.53% to -$5.1 million in 2022, then soared by 1390.45% to $65.3 million in 2023, then tumbled by 97.45% to $1.7 million in 2024, then tumbled by 1519.15% to -$23.6 million in 2025.
  • The last three reported values for Net Cash Flow were -$23.6 million (Q4 2025), $23.3 million (Q3 2025), and -$55.1 million (Q2 2025) per Business Quant data.